Neurology News and Research

Latest Neurology News and Research

BGU study: Voting causes stress and induces measurable hormonal changes

As the United States nears another election day, researchers at Ben-Gurion University of the Negev (BGU) have determined scientifically, for the first time, that voting is a stressful event, inducing measurable hormonal changes.

15 Sep 2011

Telestroke appears to be cost-effective for rural hospitals

In a first of its kind study, researchers have found that using two way audio-video telemedicine to deliver stroke care, also known as telestroke, appears to be cost-effective for rural hospitals that don't have an around-the-clock neurologist, or stroke expert, on staff.

15 Sep 2011

Encouraging results from Alexion's eculizumab Phase 2 study on generalized myasthenia gravis

Alexion Pharmaceuticals, Inc. today announced that the Company's study of eculizumab in a small group of 14 patients with severe and refractory generalized myasthenia gravis, an ultra-rare and debilitating form of generalized myasthenia gravis (gMG), showed a strong disease improvement signal.

15 Sep 2011

Researchers discover several chemical compounds against human prion diseases

In a new study NYU School of Medicine researchers report that they have found several chemical compounds, including an antidepressant, that have powerful effects against brain-destroying prion infections in mice, opening the door to potential treatments for human prion diseases.

15 Sep 2011

Jefferson neurologist receives Harold G. Wolff Lecture Award for migraine headache model

Michael L. Oshinsky, Ph.D., assistant professor of Neurology at Jefferson Medical College of Thomas Jefferson University, and a member of the Jefferson Headache Center team, was recently named the 2011 Harold G. Wolff Lecture award recipient for creating a new animal model of migraine headache.

14 Sep 2011

High cholesterol and Alzheimer's disease

New research suggests that high cholesterol levels could boost the risk of Alzheimer's disease by creating more brain-clogging bits known as plaque. Researchers however didn't find any link between high cholesterol and tangles, which also clog the brain in those with Alzheimer's.

13 Sep 2011

A squirt of insulin up the nose for prevention of Alzheimer’s disease

Researchers have noted in a small pilot study that squirting insulin deep into the nose where it travels to the brain might hold early Alzheimer’s disease at bay. At present there are no effective ways to prevent or delay the progress of Alzheimer’s. More than 5.4 million Americans and 35 million people worldwide have Alzheimer's, the most common form of dementia.

13 Sep 2011

New data from Bayer's investigational oncology compounds to be presented at ECCO-ESMO congress

Bayer HealthCare announced today that the company will present data on several of its investigational compounds at the 2011 European Multidisciplinary Cancer Congress (ECCO-ESMO), September 23-27, 2011, in Stockholm, Sweden.

13 Sep 2011

Majority of cryoballoon ablation patients show no signs of A-Fib year after procedure

Many patients are responding to a new, minimally invasive way of treating irregular heartbeats by freezing out the bad cells. Atrial fibrillation (A-Fib) is one such heart rhythm disorder, and it's the most common arrhythmia affecting Americans.

13 Sep 2011

People with high cholesterol more likely to develop Alzheimer's disease

People with high cholesterol may have a higher risk of developing Alzheimer's disease, according to a study published in the September 13, 2011, issue of Neurology, the medical journal of the American Academy of Neurology.

13 Sep 2011

Hawthorn, CoPlex Therapeutics sign licensing deal to develop and commercialize hawAD14 for Alzheimer's

Hawthorn Pharmaceuticals, Inc. announced today an exclusive global licensing deal with CoPlex Therapeutics on hawAD14, a preclinical oral small molecule candidate for the treatment of Alzheimer's and other neurodegenerative diseases.

13 Sep 2011

Clinical trial planned in Australia and the USA to help patients with ‘orphan’ disease

Prana Biotechnology Limited announced today that researchers are planning recruitment for a phase II clinical trial of the experimental drug PBT2 in Huntington’s patients. There are currently no treatments for the genetic, neurodegenerative disease; Australia is increasingly seen as a leader in the development of therapies for neurologic disorders. Huntington’s often affects young adults and progressively impacts the body, mind and emotions. The disease causes incapacitation and death about 15-25 years after onset.

12 Sep 2011

Risks of infectious disease outbreak portrayed in the film 'Contagion' are 'very real'

In this New York Times opinion piece, W. Ian Lipkin, a professor of epidemiology and a professor of neurology and pathology at Columbia University and a paid technical consultant on the film "Contagion," which opened this weekend, writes about the risks of an infectious disease outbreak as portrayed in the film, stating, "Those risks are very real -- and are increasing drastically."

12 Sep 2011

Lund University professor receives Fernström Foundation Nordic Prize for brain cell transplants

This year's Fernström Foundation Nordic Prize, with prize money of SEK 1 million, goes to Professor Anders Björklund from Lund University, Sweden. He is a neurology researcher focusing on neurodegenerative diseases, diseases in which the nerve cells die. Professor Björklund's research group is trying to develop customised stem cells to treat Parkinson's disease.

12 Sep 2011

Huge economic, social and personal burden of AF-related strokes across Latin America

Urgent coordinated action from national governments, medical societies and patient organizations is needed to avoid a public health crisis resulting from the tide of preventable strokes that leave many people with atrial fibrillation (AF) mentally and physically disabled or dead, every year. How Can We Avoid a Stroke Crisis in Latin America?, a report from Action for Stroke Prevention - a group of health experts from around the world - reveals the huge economic, social and personal burden of AF-related strokes across the region.

12 Sep 2011

Work intensity of physicians across several specialties is fairly equal: Study

Contrary to longstanding assumptions, new findings suggest the work intensity of physicians across several specialties is fairly equal. The study, funded by the American Academy of Neurology along with several other medical associations and published online ahead of print in the journal Medical Care, provides the groundwork for the development of a more reliable, scientific measurement of physician work intensity that may guide future national policy in patient safety, practice management and payment.

12 Sep 2011

Diamyd receives NIH grant to develop NTDDS for Chemotherapy Induced Peripheral Neuropathy

Diamyd Medical AB with collaborators has received a three million dollar grant from the US National Institutes of Health to develop the Company's patented Nerve Targeting Drug Delivery System (NTDDS) for prevention of Chemotherapy Induced Peripheral Neuropathy.

12 Sep 2011

WSU researcher receives $418,000 NINDS grant to study spinal muscular atrophy

Graham Parker, Ph.D., assistant professor of research in the Department of Pediatrics at Wayne State University's School of Medicine, was awarded $418,000 from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health to study how a particular gene might be involved in the progression of spinal muscular atrophy (SMA) - the number one genetic killer of children younger than 2 years old.

12 Sep 2011

Febrile seizures in children may be linked to respiratory alkalosis

New research shows that febrile seizures in children may be linked to respiratory alkalosis, indicated by elevated blood pH and low carbon dioxide levels caused by hyperventilation, and independent of the underlying infection severity.

12 Sep 2011

NIH awards $13M grant to BMC for brain abnormality study in former ELGANS

Researchers and clinicians from Boston Medical Center (BMC) have been awarded a four year, more than $13 million grant from the National Institutes of Health (NIH) to study neurological and brain abnormalities in former extremely low gestational age newborns.

12 Sep 2011

Neurology News and Research

Latest Neurology News and Research

BGU study: Voting causes stress and induces measurable hormonal changes

Telestroke appears to be cost-effective for rural hospitals

Encouraging results from Alexion's eculizumab Phase 2 study on generalized myasthenia gravis

Researchers discover several chemical compounds against human prion diseases

Jefferson neurologist receives Harold G. Wolff Lecture Award for migraine headache model

High cholesterol and Alzheimer's disease

A squirt of insulin up the nose for prevention of Alzheimer’s disease

New data from Bayer's investigational oncology compounds to be presented at ECCO-ESMO congress

Majority of cryoballoon ablation patients show no signs of A-Fib year after procedure

People with high cholesterol more likely to develop Alzheimer's disease

Hawthorn, CoPlex Therapeutics sign licensing deal to develop and commercialize hawAD14 for Alzheimer's

Clinical trial planned in Australia and the USA to help patients with ‘orphan’ disease

Risks of infectious disease outbreak portrayed in the film 'Contagion' are 'very real'

Lund University professor receives Fernström Foundation Nordic Prize for brain cell transplants

Huge economic, social and personal burden of AF-related strokes across Latin America

Work intensity of physicians across several specialties is fairly equal: Study

Diamyd receives NIH grant to develop NTDDS for Chemotherapy Induced Peripheral Neuropathy

WSU researcher receives $418,000 NINDS grant to study spinal muscular atrophy

Febrile seizures in children may be linked to respiratory alkalosis

NIH awards $13M grant to BMC for brain abnormality study in former ELGANS

Aneuro: Advancing Neuroscience Research eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Neurology News and Research

Latest Neurology News and Research

Aneuro: Advancing Neuroscience Research eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in